喘的发展与在生命早期的病毒感染期间粘膜IL-10的低水平有关
Mathias Elsner Melgaard1, Signe Kjeldgaard Jensen1, Anders Eliasen1,2
1COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Allergy
|September 2, 2024
概括
早期的病毒性呼吸道感染可以改变呼吸道免疫力. 患有喘的儿童在这些病毒发作期间显示出调节性免疫媒介介介-10 (IL-10) 的水平降低.
科学领域:
- 儿科呼吸系统医学 儿科呼吸系统医学
- 免疫学 免疫学 免疫学
- 喘研究 喘研究
背景情况:
- 生命早期的病毒感染是严重呼吸道疾病的常见触发因素.
- 这些感染是随后发展喘的已知的危险因素.
- 潜在的机制,特别是人类异常的呼吸道免疫反应,仍未得到充分研究.
研究的目的:
- 在幼儿急性呼吸道疾病期间,检查上呼吸道免疫媒介水平的病毒特异性差异.
- 确定这些免疫特征与喘晚期发展之间的关联.
主要方法:
- 分析了来自COPSAC2010队列的277名儿童 (0-3岁) 的493次急性呼吸道疾病发作.
- 用高灵敏度测试测量鼻上皮质内膜液中的18种免疫媒介.
- 病毒阳性和病毒阴性病例之间的中间体水平的比较和与6岁时喘发展的关联.
主要成果:
- 病毒检测与1型 (例如,IFN-ɣ,TNF-α) 和调节性 (例如,IL-10) 媒介的增加以及2/17型 (例如,CCL13,CXCL8) 媒介的减少相关.
- 后来患上喘的儿童在病毒发作期间的IL-10水平明显低于非喘儿童.
- 针对病毒感染和随后的喘诊断,确定了特定的免疫媒介概况.
结论:
- 这项研究描述了在生命早期病毒性呼吸道疾病期间的呼吸道免疫媒介的特征.
- 病毒感染期间调节性免疫媒介IL-10的水平降低与6岁时喘发育有关.
- 这些发现提供了关于早期病毒暴露,呼吸道免疫反应和儿童喘病变之间的关键相互作用的见解.
更多相关视频
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
30.1K
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
1.4K
相关概念视频
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:20Asthma: Pathogenesis and Management
374
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
374
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
251
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
251
01:22Development of Immunocompetence
295
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
295
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
246
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
246